Literature DB >> 10087423

Intercellular adhesion molecule-1 and hepatocyte growth factor in human endometriosis: original investigation and a review of literature.

T Fukaya1, J Sugawara, H Yoshida, T Murakami, A Yajima.   

Abstract

Defects in the cell-mediated immune system may play a role in the pathogenesis or progression of pelvic endometriosis. Possible mediators include macrophages, interleukins-1 and -6, and tumor necrosis factor-alpha. More recent work points to the involvement of adhesion molecules and growth factors. To clarify the pathogenesis of endometriosis, we compared the characteristics of soluble intercellular adhesion molecule-1 (soluble ICAM-1) and hepatocyte growth factor (HGF) in women with and without endometriosis. We found that, in patients with endometriosis, the concentrations of soluble ICAM-1 in peritoneal fluid increased and interfered with the activity of natural killer cells. We also found that HGF secretion was significantly increased in cultured endometrial stromal cells, and that HGF stimulated the proliferation and migration of, and morphogenic changes in, endometrial epithelial cells. HGF and ICAM-1 play important roles in the initiation and regulation of endometriotic lesions on the microenvironment level. The increased secretion of HGF by eutopic endometrial stromal cells may contribute to the pathogenesis of endometriosis, whereas the increased levels of soluble ICAM-1 may impair natural killer cell activity and accelerate the progression of the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10087423     DOI: 10.1159/000052854

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  9 in total

1.  Modulation of hepatocyte growth factor secretion in human female reproductive tract stromal fibroblasts by poly (I:C) and estradiol.

Authors:  Kimberly D Coleman; Mimi Ghosh; Sarah G Crist; Jacqueline A Wright; Richard M Rossoll; Charles R Wira; John V Fahey
Journal:  Am J Reprod Immunol       Date:  2011-08-23       Impact factor: 3.886

Review 2.  The Promises of Natural Killer Cell Therapy in Endometriosis.

Authors:  Janneke Hoogstad-van Evert; Romy Paap; Annemiek Nap; Renate van der Molen
Journal:  Int J Mol Sci       Date:  2022-05-16       Impact factor: 6.208

Review 3.  Endometrial biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Devashana Gupta; M Louise Hull; Ian Fraser; Laura Miller; Patrick M M Bossuyt; Neil Johnson; Vicki Nisenblat
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20

Review 4.  Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach.

Authors:  Nadja Tariverdian; Theoharis C Theoharides; Friederike Siedentopf; Gabriela Gutiérrez; Udo Jeschke; Gabriel A Rabinovich; Sandra M Blois; Petra C Arck
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 9.623

Review 5.  Potential involvement of the immune system in the development of endometriosis.

Authors:  Cleophas M Kyama; Sophie Debrock; Jason M Mwenda; Thomas M D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2003-12-02       Impact factor: 5.211

Review 6.  Decreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis.

Authors:  InCheul Jeung; Keunyoung Cheon; Mee-Ran Kim
Journal:  Biomed Res Int       Date:  2016-05-12       Impact factor: 3.411

Review 7.  Adhesion in Physiological, Benign and Malignant Proliferative States of the Endometrium: Microenvironment and the Clinical Big Picture.

Authors:  Emily J Rutherford; Arnold D K Hill; Ann M Hopkins
Journal:  Cells       Date:  2018-05-16       Impact factor: 6.600

Review 8.  NK Cells as Potential Targets for Immunotherapy in Endometriosis.

Authors:  Aneta Ścieżyńska; Michał Komorowski; Marta Soszyńska; Jacek Malejczyk
Journal:  J Clin Med       Date:  2019-09-14       Impact factor: 4.241

9.  Evaluation of apoptosis and angiogenesis in ectopic and eutopic stromal cells of patients with endometriosis compared to non-endometriotic controls.

Authors:  Ali-Akbar Delbandi; Mahmoud Mahmoudi; Adel Shervin; Sahel Heidari; Roya Kolahdouz-Mohammadi; Amir-Hassan Zarnani
Journal:  BMC Womens Health       Date:  2020-01-06       Impact factor: 2.809

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.